BioIQ raises $2.5M
Santa Barbara-based BioIQ, which develops healthcare information technology, said Wednesday that it has raised $2.5M in a Series B funding.
Juvaris BioTherapeutics Inc., a Pleasanton, Calif.-based developer of vaccines for cancer and infectious diseases, has raised $25 million in the first close of a Series B round.